Systemic Lupus Erythematosus (SLE) diagnosed during hospitalization:greater disease activity, damage and short-term death

被引：0
|
作者：
Hassan, R. I. [1 ]
Porta, S. [1 ]
Aquino, V. [1 ]
Estrella, N. [1 ]
Sequeira, G. [1 ]
Kerzberg, E. [1 ]
机构：
[1] Hosp JM Ramos Mejia, Serv Reumatol, Buenos Aires, DF, Argentina
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2015年 / 33卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P5.52
引用
收藏
页码：S52 / S52
页数：1
相关论文
共 50 条
  • [21] Predictors of disease activity and disease damage in pediatric systemic lupus erythematosus
    Hiraki, L. T.
    Benseler, S. M.
    Tyrrell, P. N.
    Hebert, D.
    Harvey, E.
    Silverman, E. D.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 116 - 116
  • [22] ASSOCIATION BETWEEN SYSTEMIC LUPUS ERYTHEMATOSUS AND SHORT-TERM MORTALITY IN SEPSIS
    Sidhu, Mandeep
    Garza, John
    Raheem, Abdur
    Dang, Thao
    Panchagnula, Neha
    Mahmood, Saima
    Tariq, Hina
    Oud, Lavi
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 254 - 254
  • [23] THERAPEUTIC STRATEGY AND SHORT-TERM OUTCOME IN NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS
    Bortoluzzi, A.
    Fanouriakis, A.
    Appenzeller, S.
    Carli, L.
    Carrara, G.
    Conti, F.
    Costallat, L.
    De Marchi, G.
    De Vita, S.
    Doria, A.
    Fredi, M.
    Hanly, J. G.
    Murphy, E.
    Mathieu, A.
    Mosca, M.
    Pelusi, M.
    Piga, M.
    Scire, C.
    Silvagni, E.
    Tincani, A.
    Tomietto, P.
    Truglia, S.
    Zen, M.
    Bertsias, G.
    Govoni, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1411 - 1411
  • [24] Effects of short-term infliximab therapy on autoantibodies in systemic lupus erythematosus
    Aringer, Martin
    Steiner, Guenter
    Graninger, Winfried B.
    Hoefler, Elisabeth
    Steiner, Carl W.
    Smolen, Josef S.
    ARTHRITIS AND RHEUMATISM, 2007, 56 (01): : 274 - 279
  • [25] Lupus headaches (LHA) and their impact on disease activity measured by the SLEDAI and the prediction of damage (SLICC) in juvenile systemic lupus erythematosus (SLE).
    Brunner, HI
    Jones, O
    Lovell, DJ
    Tomasi, AM
    Klein-Gitelman, MS
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S262 - S262
  • [26] Thyroid dysfunction in patients with systemic lupus erythematosus (SLE): relation to disease activity
    Mader, Reuven
    Mishail, Samer
    Adawi, Muhammed
    Lavi, Idit
    Luboshitzky, Rafael
    CLINICAL RHEUMATOLOGY, 2007, 26 (11) : 1891 - 1894
  • [27] IGG SUBCLASS LEVELS AND DISEASE-ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
    MAYUS, J
    KAINE, J
    NAHM, M
    FEDERATION PROCEEDINGS, 1985, 44 (05) : 1716 - 1716
  • [28] Serum Albumin as a Marker for Disease Activity in Patients with Systemic Lupus Erythematosus (SLE)
    Yip, Jonathan
    Aghdassi, Ellie
    Su, Jiandong
    Lou, Wendy
    Reich, Heather
    Bargman, Joanne
    Scholey, James
    Gladman, Dafna
    Urowitz, Murray
    Fortin, Paul R.
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (06) : 1326 - 1326
  • [29] Thyroid dysfunction in patients with systemic lupus erythematosus (SLE): relation to disease activity
    Reuven Mader
    Samer Mishail
    Muhammed Adawi
    Idit Lavi
    Rafael Luboshitzky
    Clinical Rheumatology, 2007, 26 : 1891 - 1894
  • [30] EFFECTS OF VARIOUS IMMUNOSUPPRESSANTS IN THE DISEASE DAMAGE AMONG PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
    Shaharir, S. S.
    Ding, H. J.
    Rajalingham, S.
    Said, M. S. Mohamed
    Kong, N. C. T.
    Hussein, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 255 - 255
12345